COCH

Anzu SPAC GP I LLC

Known title: 10% OwnerCIK: 0001846378

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 29, 2026

Envoy Medical Adds Two New Patents to Global Portfolio. Envoy Medical announced it has been granted two additional global patents, further expanding its intellectual property portfolio. This development strengthens the company's protection for its medical technologies. The stock is currently trading near its 52-week low, with an average analyst target of $2.00.

this person other insiders at COCH

Transaction History

COCH▼ Sell$0
COCH▼ Sell$0
COCH▼ Sell$0
COCH▼ Sell—
COCH▼ Sell—

We use analytics to understand how market-wall is used. No personal data is sold.